Time course and predictors of use of erectile dysfunction treatment in a Veterans Affairs medical center.

R I Clavijo, T Daskivich, L Kwan, J Bassett, T Keller, C Bennett

Abstract read

In one paragraph

Article in International journal of impotence research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 40% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

An increased prevalence of medical co-morbidities may underscore future growth in the numbers of men requiring penile prostheses.Translational andrology and urology · 2017
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

R I ClavijoDepartment of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

T DaskivichDepartment of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

L KwanDepartment of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

J BassettKaiser Permanente, Anaheim, CA, USA.

T KellerGreater Los Angeles Veterans Affairs Medical Center, Los Angeles, CA, USA.

C BennettDepartment of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

University of California, Los Angeles · USWest Los Angeles College · USKaiser Permanente Anaheim Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to define the pattern and time course of use of ED treatments in a Veterans Affairs (VA) medical center and to identify clinical or demographic variables that are associated with the use of second- or third-line ED treatments. We identified 702 men treated for ED at the Greater Los Angeles Veterans Affairs between 2007 and 2013. We extracted demographics, Charlson co-morbidity score, pertinent surgical/medication history as well as use of ED treatments from medical records. On multivariate analysis, age over 65 (OR 1.83, 95% CI: 1.31-2.56) and Charlson co-morbidity score of 1 (OR 1.77, 95% CI: 1.13-2.77) and 2+ (OR 2.07, 95% CI: 1.28-3.36) were significantly associated with use of medicated urethral suppositories for erection (MUSE)/intracorporal injections (ICI) compared with PDE5i/erection devices. Across all men who used second- or third-line treatments, median time until receiving MUSE was 0.6 years and median time until receiving ICI/implant was 2 years. We conclude that men who will ultimately use more invasive ED treatments, such as men with more co-morbidities, tend to have a prolonged treatment course. This information may be incorporated into a shared decision-making model for more efficient treatment of ED.

Indexed as

Patient Acceptance of Health CarePenile ImplantationVeteransAgedAge FactorsErectile DysfunctionHumansMaleMiddle AgedPenile ErectionPenile ProsthesisPhosphodiesterase 5 InhibitorsUnited StatesUnited States Department of Veterans AffairsPhosphodiesterase 5 Inhibitors

Identifiers

PMID27193063

DOI10.1038/ijir.2016.20

OpenAlexW2403587418

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.